A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants
about
Retinopathy of prematurity: Past, present and futureAn ocular view of the IGF-IGFBP systemIGF-I in the clinics: Use in retinopathy of prematurityThe mouse retina as an angiogenesis model.Retinopathy of prematurity: the need for prevention.Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safetyUnderstanding retinopathy of prematurity: update on pathogenesis.Retinopathy of prematurity promising newer modalities of treatment.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic optionsPersonalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Current update on retinopathy of prematurity: screening and treatmentReview of the mechanisms and therapeutic avenues for retinal and choroidal vascular dysfunctions in retinopathy of prematurity.IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.The role of serum apelin in retinopathy of prematurity.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Prediction of severe retinopathy of prematurity using the WINROP algorithm in a birth cohort in South East Scotland.Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.Effect of insulin-like growth factor-I during the early postnatal period in intrauterine growth-restricted rats.
P2860
Q26767012-D34DC5A2-0DAA-45F2-BA64-752A09182E43Q27013698-C2E7EAFC-AB55-41E1-8E0B-40705D9CE7E7Q28070089-0966AE9C-EAB0-4261-A82D-A9670F3627C4Q30495106-FB10CE9D-E726-4E7D-9255-29D0CCB5A268Q33585466-F6F70AD3-E575-430C-8A2B-D9640BBB5769Q33640027-E346AF22-FCE8-48E8-9FA4-C049FC30C11DQ34038976-7F0660DE-C506-4604-9760-057FADC7E3E6Q34192101-77C0C2CA-5C20-45C0-BC76-56B515ADBCDEQ34358139-2E799DA0-0AC7-405B-BFB0-29A19A1E21C3Q34704214-2AEDE993-3A3A-4B4D-9742-AEC9CDA5F963Q37627442-5AB3EF37-7190-4F2E-B6F3-30EB3987ED1CQ37819879-18AA47A6-05CB-40B1-B905-E7A7BA20D3E4Q38952692-9AC3B85B-467D-4BFD-945C-CCE151C3A53EQ38960055-BE0D0CAC-B912-44BB-9EDE-C3C865FBEB85Q39167922-B615D392-C09A-42D5-BB8C-FF5912943413Q42319662-9B05379B-001E-411F-99C9-881D77F341B2Q47568034-4DB58E93-6F92-4917-836F-0399F10C4E83Q47679810-0CA3B4FC-E0F1-43DE-AC23-CADD0116328BQ51746396-3E33C724-E889-40A4-AFB0-4FBE376E47D6Q52145506-E49D2C21-5611-4C4A-A888-DA2148E40A81
P2860
A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@ast
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@en
type
label
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@ast
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@en
prefLabel
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@ast
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@en
P2093
P2860
P1433
P1476
A pharmacokinetic and dosing s ...... n-3 complex to preterm infants
@en
P2093
Aimon Niklasson
Cecilia Camacho-Hübner
Eva Engström
Lena E Friberg
Lois E H Smith
P2860
P2888
P304
P356
10.1203/PDR.0B013E31819D9E8C
P407
P577
2009-05-01T00:00:00Z
P6179
1009549753